Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fallopian Tubes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04440943
What this trial is testing

The PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerBreast CancerGastric Cancer+11 more
Celldex Therapeutics 27
Very early researchActive Not RecruitingNCT05053750
What this trial is testing

TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Epithelial OvarianFallopian TubePrimary Peritoneal Cancer
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Ended earlyNCT02389985
What this trial is testing

CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Ovarian Cancer
NewLink Genetics Corporation 30
Not applicableUnknownNCT03717610
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy for Treatment of Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer Recurrent
Uppsala University Hospital 10
Testing effectiveness (Phase 2)Study completedNCT01523678
What this trial is testing

Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers

Who this might be right for
Ovarian CancerEndometrial CancerUterine Cervical Cancer
Belgian Gynaecological Oncology Group 108
Not applicableEnded earlyNCT00968799
What this trial is testing

Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study

Who this might be right for
Epithelial Ovarian CancerFallopian Tube Carcinoma
Cantonal Hospital of St. Gallen 6
Testing effectiveness (Phase 2)Study completedNCT00217555
What this trial is testing

Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Fred Hutchinson Cancer Center
Early research (Phase 1)Looking for participantsNCT06366490
What this trial is testing

Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerRecurrent Epithelial Ovarian Cancer Which Includes Epithelial Ovarian, Fallopian Tube and/or Primary Peritoneal Cancer
PhotonPharma, Inc. 8
Early research (Phase 1)Ended earlyNCT00003380
What this trial is testing

Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT02873962
What this trial is testing

A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

Who this might be right for
Peritoneal CancerOvarian CancerFallopian Tube Cancer
Dana-Farber Cancer Institute 72
Very early researchUnknownNCT05801783
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer

Who this might be right for
Ovarian CancerPeritoneal CarcinomatosisFallopian Tube Cancer
Shanghai Yunying Medical Technology 10
Testing effectiveness (Phase 2)UnknownNCT00005025
What this trial is testing

Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
John Stoddard Cancer Center at Iowa Methodist Medical Center
Testing effectiveness (Phase 2)Study completedNCT02853318
What this trial is testing

Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+11 more
Roswell Park Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT01246440
What this trial is testing

Catumaxomab as a Consolidation Therapy in Patients With Ovarian Cancer in Second or Third Clinical Disease Remission

Who this might be right for
Ovarian Cancer
Grupo Español de Investigación en Cáncer de Ovario 39
Not applicableStudy completedNCT02489058
What this trial is testing

Long-Term Responders on Olaparib

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
University Health Network, Toronto 118
Not applicableStudy completedNCT04628455
What this trial is testing

Needlescopic Inversion and Snaring of Hernia in Girls

Who this might be right for
Inguinal HerniaPolypsFallopian Tube Injury+1 more
Al-Azhar University 53
Large-scale testing (Phase 3)WithdrawnNCT01492920
What this trial is testing

Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy

Who this might be right for
FatigueMalignant Ovarian Mixed Epithelial TumorNeuropathy+10 more
Gynecologic Oncology Group
Not applicableStudy completedNCT01295489
What this trial is testing

Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CarcinomaOvarian CarcinomaPrimary Peritoneal Carcinoma
Gynecologic Oncology Group 39
Testing effectiveness (Phase 2)Ended earlyNCT01773889
What this trial is testing

A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerExtraovarian Peritoneal CancerFallopian Tube Carcinoma
The University of Texas Health Science Center at San Antonio 2
Testing effectiveness (Phase 2)Study completedNCT01175343
What this trial is testing

RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+3 more
National Cancer Institute (NCI) 45
Next Page